Michael Sumner

Michael Sumner

M.D. Chief Medical Officer and Head of DevelopmentatInovio Pharmaceuticals· In proxies 2024–2025

Pay in FY2025-12% from the year before · Inovio Pharmaceuticals stock -4.9% the same year

Michael Sumner was paid $910.6K in FY2025 (Dec), down 12%. Inovio Pharmaceuticals stock fell 4.9% that year.

Pay$100 in the stock at the end of FY23 → $28
Pay is from the Summary Compensation Table of each Inovio Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inovio PharmaceuticalsPublic company · 2 yr
    • M.D. Chief Medical Officer and Head of Development2024 – Present · 2 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?